The global colostrum supplements market was valued at USD 3.80 billion in 2025 and is estimated to reach USD 4.01 billion in 2026 before growing to USD 5.51 billion by 2031, according to a ResearchAndMarkets.com report. The market is forecast to expand at a 6.58% compound annual growth rate (CAGR) during 2026-2031, with estimates provided by value in USD and volume in tons. Demand is being supported by interest in immune health, preventive wellness, sports nutrition, muscle recovery, clean-label products and naturally derived bioactive ingredients. Bovine colostrum held 88.61% of the market in 2025, while goat colostrum is forecast to be the fastest-growing source segment at a 7.32% CAGR. North America accounted for 36.91% of the market in 2025, and Asia-Pacific is projected to grow fastest, at a 7.87% CAGR through 2031. Regulatory limits on therapeutic and disease-related claims remain a restraint: the Food and Drug Administration (FDA), the U.S. food and drug regulator, governs dietary supplement claims under 21 CFR 101.93. The report also examines supply constraints, clinical evidence, animal-welfare concerns, processing technology, consumer behavior, competition and regional markets.